Security Snapshot

NRC HEALTH - Common Stock (NRC) Institutional Ownership

CUSIP: 637372202

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

121

Shares (Excl. Options)

10.75MFull value: 10,751,235 · shares · 30 Jun 2026

Price

$21.57

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
NRC on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
10,751,235
Latest holder snapshot 5 signals
Total 13F value
$231,865,585
Portfolio coverage rank
0%
Share change
-76,484
Value change
-$966,004
Number of holders
121
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
22,561,022
SEC-reported price per share
$21.19
Insider filing price
$21.19
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NRC - NRC HEALTH - Common Stock is tracked under CUSIP 637372202.
  • 121 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 119 to 121 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $184.22MFull value: $184,219,586 · USD · 31 Mar 2026
    to
    $231.87MFull value: $231,865,585 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 121 institutions filings for Q2 2026.

Open SEC evidence

Security key

637372202

13F reference period

Q2 2026

13F holders

121

13D/G owners

3

CIK / CUSIP context first

Open Q2 2026 holders NRC full holder history NRC HEALTH SEC filings NRC HEALTH company facts NRC HEALTH insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
NRC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Common Property Trust 46% -0.87% $173,546,877 -$4,715,705 10,305,634 -2.6% Beans Patrick E. 10 Jun 2026
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 9% -22% $44,325,640 -$13,694,832 2,030,492 -24% Kayne Anderson Rudnick Investment Management, LLC 30 Jun 2026
BlackRock, Inc. 4.4% -14% $10,850,303 -$2,050,837 1,014,047 -16% BlackRock, Inc. 31 Mar 2025
As of 30 Jun 2026, 121 institutional investors reported holding
10.75MFull value: 10,751,235 · shares · 30 Jun 2026
shares of NRC HEALTH - Common Stock (NRC). This represents 48% of the company’s total
22.56MFull value: 22,561,022 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
42%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 9% 2,030,492 -23% 0.14% $43,797,714
BlackRock, Inc. 4.7% 1,061,355 +8.8% 0% $22,893,428
MORGAN STANLEY 3.8% 859,268 -14% 0% $18,534,426
VANGUARD CAPITAL MANAGEMENT LLC 3% 666,554 +0.56% 0% $14,377,570
DIMENSIONAL FUND ADVISORS LP 2.2% 491,228 +0.3% 0% $10,595,956
Willis Investment Counsel 1.9% 434,785 +94% 0.45% $9,378,312
GEODE CAPITAL MANAGEMENT, LLC 1.9% 420,056 +6.7% 0% $9,062,880
QV Investors Inc. 1.7% 372,503 -2.3% 0.62% $8,035,000
FARMERS & MERCHANTS INVESTMENTS INC 1.5% 330,649 +330549% 0.17% $7,132,099
RENAISSANCE TECHNOLOGIES LLC 1.4% 325,384 -4.5% 0.01% $7,018,533
HEARTLAND ADVISORS INC 1.3% 300,000 +27% 0.29% $6,471,000
STATE STREET CORP 1.3% 298,384 -0.79% 0% $6,483,381
Bank of New York Mellon Corp 1.1% 252,235 +0.61% 0% $5,440,710
NORTHERN TRUST CORP 1.1% 238,243 -6.8% 0% $5,138,900
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.83% 187,920 -34% 0.01% $4,053,434
iA Global Asset Management Inc. 0.83% 187,520 0% 0.05% $4,045,000
WELLS FARGO & COMPANY/MN 0.8% 179,623 +54% 0% $3,874,460
AQR CAPITAL MANAGEMENT LLC 0.54% 122,206 -29% 0% $2,635,976
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.5% 113,312 +0.83% 0% $2,444,140
Northwest & Ethical Investments L.P. 0.45% 102,370 -21% 0.05% $2,208,121
VANGUARD FIDUCIARY TRUST CO 0.43% 97,200 +4.3% 0% $2,096,604
GOLDMAN SACHS GROUP INC 0.43% 96,776 +17% 0% $2,087,458
JANE STREET GROUP, LLC 0.39% 87,375 +24% 0% $1,884,679
FIFTH THIRD BANCORP 0.38% 85,372 -5.3% 0% $1,841,475
BANK OF AMERICA CORP /DE/ 0.37% 82,946 -26% 0% $1,789,145

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,404,482 $29,752,805 +$3,739,663 $21.19 22
2026 Q2 10,751,235 $231,865,585 -$966,004 $21.57 121
2026 Q1 10,844,286 $184,219,586 +$3,115,506 $16.98 119
2025 Q4 10,745,800 $201,606,565 -$5,605,734 $18.77 116
2025 Q3 11,109,644 $142,023,248 -$7,941,184 $12.78 116
2025 Q2 11,671,181 $196,114,843 +$3,893,782 $16.80 124
2025 Q1 11,503,564 $147,284,867 -$6,206,822 $12.80 122
2024 Q4 11,878,871 $209,583,639 -$2,343,384 $17.64 132
2024 Q3 11,934,034 $272,840,522 -$6,927,729 $22.86 137
2024 Q2 12,182,341 $279,622,437 -$21,335,705 $22.95 132
2024 Q1 12,745,050 $505,224,889 +$28,006,688 $39.61 141
2023 Q4 12,021,040 $475,597,179 -$3,757,713 $39.56 129
2023 Q3 12,126,634 $538,449,269 +$20,270,452 $44.37 120
2023 Q2 11,662,652 $507,799,722 +$9,048,952 $43.51 115
2023 Q1 11,452,078 $498,653,789 -$4,356,439 $43.51 123
2022 Q4 11,704,412 $437,476,387 +$36,764,570 $37.30 115
2022 Q3 11,675,608 $464,909,449 +$5,806,059 $39.80 109
2022 Q2 11,521,526 $440,979,718 +$947,742 $38.28 108
2022 Q1 11,507,618 $456,280,796 +$3,529,770 $39.65 114
2021 Q4 11,416,748 $473,681,626 +$4,397,518 $41.52 111
2021 Q3 11,228,351 $473,712,379 +$2,204,108 $42.17 108
2021 Q2 11,179,409 $514,210,467 +$12,286,535 $45.90 100
2021 Q1 10,907,137 $511,278,633 +$5,950,900 $46.83 96
2020 Q4 10,781,336 $461,751,144 +$8,374,142 $42.75 90
2020 Q3 10,532,859 $519,036,815 -$2,532,454 $49.21 91
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .